Stay updated on Lazertinib vs Intravenous Amivantamab in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Lazertinib vs Intravenous Amivantamab in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lazertinib vs Intravenous Amivantamab in Lung Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    New update timestamps (2026-07-06, 2026-07-02, 2026-07) were added and older ones (2026-06-08, 2026-06-04, 2026-06) removed in the study's record dates, reflecting the current update chronology.
    Difference
    0.1%
    Check dated 2026-07-07T09:51:54.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Revision label on the page changed from v3.6.0 to v3.6.3, indicating a newer version of the page. This appears to be a revision history update rather than a substantive change to the study content or user-facing information.
    Difference
    0.0%
    Check dated 2026-06-30T05:40:48.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    The study page now shows recruitment is closed, indicating that no further participant enrollment is expected. Additionally, there are minor UI/navigation updates and a version label reflecting the page's revision.
    Difference
    0.2%
    Check dated 2026-06-16T00:24:43.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    New revision markers and dates have been added to the page's history (including Revision: v3.5.5 on 2026-06-08 and 2026-06-04), while older revision entries (including v3.5.4) and May dates were removed, indicating an update to the documentation.
    Difference
    0.1%
    Check dated 2026-06-09T01:08:10.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Revision updated from v3.5.3 to v3.5.4, representing an updated version of the study page. This change is a metadata version bump and does not modify the substantive study details.
    Difference
    0.0%
    Check dated 2026-05-18T13:49:39.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    These changes reflect updates to the study record's update history, with May 2026 timestamps added and April 2026 timestamps removed. They indicate edits to the page's metadata rather than changes to the study's design, eligibility, or outcomes.
    Difference
    0.1%
    Check dated 2026-05-11T11:45:03.000Z thumbnail image

Stay in the know with updates to Lazertinib vs Intravenous Amivantamab in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lazertinib vs Intravenous Amivantamab in Lung Cancer Clinical Trial page.